tiprankstipranks
Galmed Pharmaceuticals (GLMD)
NASDAQ:GLMD
US Market
GLMD
Galmed Pharmaceuticals
RESEARCH TOOLSreports
Want to see GLMD full AI Analyst Report?

Galmed Pharmaceuticals (GLMD) Income Statement

1,310 Followers

Galmed Pharmaceuticals Income Statement

Last quarter (Q4 2025), Galmed Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Galmed Pharmaceuticals's net income was $-4.82M. See Galmed Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -83.00K$ -31.00K$ -35.00K$ -42.00K
Operating Expenses
$ 8.51M$ 6.20M$ 7.46M$ 17.62M$ 32.84M
Depreciation and Amortization
$ 0.00$ 83.00K$ 31.00K$ 35.00K$ 42.00K
EBITDA
$ -8.51M$ -6.20M$ -7.46M$ -17.62M$ -32.84M
Operating Income
$ -8.51M$ -6.28M$ -7.49M$ -17.65M$ -32.88M
Other Income/Expenses
$ -1.80M$ -1.24M$ 580.00K$ -215.00K$ 414.00K
Pretax Income
$ -10.31M$ -7.52M$ -6.91M$ -17.87M$ -32.47M
Net Income
$ -10.31M$ -7.52M$ -6.91M$ -17.87M$ -32.47M
Per Share Metrics
Basic EPS
$ -2.39$ -8.08$ -30.05$ -11.08$ -19.48
Diluted EPS
$ -2.39$ -8.08$ -29.95$ -11.08$ -19.48
Weighted Average Shares Outstanding
 4.31M 930.82K 230.00K 1.68M 1.64M
Weighted Average Shares Outstanding (Diluted)
 4.31M 930.82K 230.79K 1.68M 1.64M
Currency in USD

Galmed Pharmaceuticals Earnings and Revenue History